| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.5 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.5 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | 0.021 | 0.5 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.6 |